[Contraception, therapeutic abortion, and pulmonary arterial hypertension].

  • Frachon I
  • Gaudin S
  • Jezequel C
 et al. 
  • 3


    Mendeley users who have this article in their library.
  • N/A


    Citations of this article.


Despite therapeutic advances, maternal mortality is high in pulmonary arterial hypertension (PAH). PAH treatment may interfere with the proposed method of contraception. Moreover, some treatments (endothelin receptor antagonists, anti-vitamin K) are teratogenic. If pregnancy is strictly not recommended in PAH, few specific contraceptive guidelines are available. The contraceptive method must be discussed on a case by case basis with the patient, the reference team for PAH, and the gynecology department.The advantages of the intrauterine device (IUD) with progesterone (reliability, simplicity, compliance, few contraindications and interactions, possibility of use in the nulliparous patient, reimbursement by the healthcare system) make it a good contraceptive choice in these circumstances. Therapeutic abortion is a situation of contraceptive failure, it must always be performed in hospitals. It must lead to effective contraceptive advice.

Author-supplied keywords

  • Abortion, Therapeutic
  • Contraception
  • Family Planning Services
  • Female
  • Gestational Age
  • Humans
  • Hypertension, Pulmonary
  • Maternal Mortality
  • Patient Selection
  • Practice Guidelines as Topic
  • Pregnancy
  • Pregnancy Complications
  • Sterilization, Reproductive
  • methods
  • mortality
  • prevention & control

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • Irene Frachon

  • Stephanie Pozzi Gaudin

  • Catherine Jezequel

  • Xavier Jais

  • Christophe Gut-Gobert

  • Sandrine Roger Christophe

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free